Cardiopulmonary complications of ergot-derivative dopamine agonists

Cardiopulmonary complications of ergot-derivative dopamine agonists

Saved in:
Bibliographic Details
Published in:The journal of clinical psychiatry Vol. 65; no. 10; pp. 1429 - 1430
Main Authors: Rack, Michael J, Baran, Alp Sinan, Richert, Allen C, Roffwarg, Howard P
Format: Journal Article
Language:English
Published: United States 01-10-2004
Subjects:
Antipsychotic Agents - adverse effects
Antipsychotic Agents - therapeutic use
Bromocriptine - adverse effects
Cabergoline
Dopamine Agonists - adverse effects
Dopamine Agonists - therapeutic use
Dose-Response Relationship, Drug
Ergolines - adverse effects
Ergolines - therapeutic use
Heart Valve Diseases - chemically induced
Heart Valve Diseases - epidemiology
Humans
Hyperprolactinemia - chemically induced
Hyperprolactinemia - drug therapy
Pergolide - adverse effects
Pulmonary Fibrosis - chemically induced
Pulmonary Fibrosis - epidemiology
Risperidone - adverse effects
Risperidone - therapeutic use
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0160-6689
DOI:10.4088/JCP.v65n1020b